Press Release
- Q1 FY27 performance showed robust top-line execution with revenue reaching ₹1,166 Cr (+45.7% YoY) and PAT of ₹54 Cr (+25% YoY).
- High-margin specialty segments are scaling fast: Rigid Packaging grew 58% YoY and turned EBIT positive, while Specialty Chemicals grew 34% with a 25% EBITDA margin.
- Management announced a 50% capacity expansion in Rigid Packaging over the next 2 quarters via low brownfield capex.
- Management guided for 20% overall revenue growth in FY27 as major ₹1,200 Cr capex cycle completes and operating leverage kicks in.
- Cyclical commodity oversupply in global BOPP/BOPET markets creates margin compression risk if raw material prices spike or spreads contract.
- Elevated debt balance of ₹1,573 Cr (D/E 1.20x) keeps interest coverage and financial leverage under scrutiny during industry downturns.
- Export market vulnerability (52% export revenue share) to US tariffs, shipping freight spikes, and global demand slowdowns.
1. Ramp-Aware Impact Math
- Q1 FY27 Baseline: Revenue hit ₹1,166 Cr (+45.7% YoY) and PAT reached ₹54 Cr. Annualizing Q1 PAT indicates a run-rate PAT of ~₹216 Cr compared to TTM PAT of ₹126 Cr.
- FY27 Revenue Guidance: 20% YoY growth targets ~₹4,250 Cr full-year revenue. With new capacities in BOPP (81.2k MT) and CPP (22k MT) operating near full utilization by Q4 FY27, revenue momentum is strong.
- Margin Expansion & EPS Impact: As Rigid Packaging turns EBIT positive and Specialty Chemicals (25% EBITDA margin) targets 10% revenue share, consolidated PAT margin is projected to expand from 3.5% (FY26) to 4.8%-5.2%. This yields an estimated FY27 PAT of ₹200-215 Cr, driving EPS from ₹54.80 to ~₹88-94 (+60-70% EPS uplift).
- Valuation Impact: At ₹872, COSMOFIRST trades at ~15.9x FY26 EPS and ~9.5x forward FY27 EPS. A modest re-rating to 14-16x forward EPS supports a target price of ₹1,250 - ₹1,450.
2. Industry Capital Intensity & Structural CAGR
- Capital Intensity: Medium. Heavy initial capex is required for BOPP/BOPET film lines, but recent additions (rigid packaging +50%) rely on low brownfield capex.
- Industry CAGR: Flexible packaging & specialty chemical industries are expanding at 8-10% CAGR in India, driven by consumer packaged goods demand and eco-friendly mono-material film transition.
3. Multibagger Quality Assessment
- Revenue & EPS Acceleration: Quarterly revenues expanded sequentially from ₹899 Cr (Q3 FY26) -> ₹1,021 Cr (Q4 FY26) -> ₹1,166 Cr (Q1 FY27). EPS expanded from ₹11.4 -> ₹14.06 -> ~₹23.5 in Q1 FY27.
- Margins & ROCE: OPM expanded past 10-11%. Trailing ROCE stands at 10.0% due to unutilized asset base during the capex cycle, but asset turnover acceleration should lift ROCE toward 14-16%.
- Balance Sheet Risk: Debt stands at ₹1,573 Cr (D/E 1.20), but net debt remained capped at ₹1,166 Cr (2.3x EBITDA) as capex peaks.
4. Calibrated Valuation Scenarios
- Base Case (+45%): FY27 Revenue reaches ₹4,150 Cr, EPS reaches ₹85. P/E re-rates to 15x -> Target ₹1,265.
- Bull Case (+80%): Specialty films & rigid packaging ramp up faster; FY27 EPS reaches ₹98 with P/E re-rating to 16x -> Target ₹1,570.
- Bear Case (-25%): Commodity film oversupply compresses spreads; gross margin contracts by ₹3-4/kg; FY27 EPS falls to ₹55, P/E de-rates to 12x -> Target ₹650.
5. Verdict Rationale
COSMOFIRST demonstrates clear earnings acceleration as a major ₹1,200 Cr capex cycle concludes and high-margin specialty verticals scale up. While commodity packaging exposure and leverage hold back a 'STRONG_CANDIDATE' rating, the strong Q1 FY27 operational uplift makes it a solid 'POSSIBLE' multibagger candidate over a 12-24 month horizon.